|
Market Closed -
Bombay S.E.
13:03:02 11/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 23,536.20 INR | -1.12% |
|
+3.94% | +54.94% |
| 09-08 | Indian shares on track for muted open as oil climbs on rising Mideast risks | RE |
| 08-06 | Neuland Laboratories Limited, Q1 2027 Earnings Call, Aug 05, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NEULAND LABORATORIES LIMITED | Other Pharmaceuticals | -1.12% | +3.94% | +54.94% | +51.25% | +1,232.14% | 3.16B |  | | |
- Stock Market
- Stocks
- NEULANDLAB Stock
- Charts Neuland Laboratories Limited
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
